Negative Pressure Wound Therapy Compared to Traditional Care After Skin Grafting

NCT ID: NCT03649308

Last Updated: 2024-02-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

160 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-09-19

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to compare negative pressure wound therapy to traditional care after split-thickness skin grafting in patients aged over 18.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Split-thickness skin grafting (STSG) is one of the most commonly used techniques in reconstructive plastic surgery and dermatology. Skin grafts are being used to cover skin defects caused by multiple etiologies. Traditionally, patients are immobilized in bed or in wheelchair for up to five days after surgery. Long immobilization decreases patients overall ability to function and increases the length of the stay in hospital. Negative pressure wound therapy (NPWT) have been used successfully in treatment of acute, chronic and diabetic ulcers. It is proposed that NPWT increases capillary blood flow, decreases bacterial contamination, seroma formation and swelling. Using NPWT on split-thickness skin grafts after burns is well documented. It increases skin graft take ratio and speeds up healing. Aim of this study is to compare NPWT to traditional treatment after STSG for any indication in patients aged 18 to 99. This is a two-arm, multicenter, randomized prospective trial with 160 patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Wound of Skin Wound Heal Wound Wound Open Wound Breakdown Skin Wound Skin Scarring

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

After split-thickness skin graft procedure, the participants are assigned to either conventional treatment or negative pressure wound therapy group in parallel for the duration of the study.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Negative Pressure Wound Therapy

A negative pressure wound therapy device (PICO) is applied on split-thickness skin graft for 5 to 7 days from surgery in operating theatre. The patient can be mobilized immediately after skin graft procedure.

Group Type EXPERIMENTAL

Negative Pressure Wound Therapy

Intervention Type DEVICE

An immediate mobilization and negative pressure wound therapy (PICO) initiated after surgery.

Conventional treatment

A conventional wound dressing is applied on wound in operating theatre, followed by immobilization for 5 days after split-thickness skin graft procedure.

Group Type ACTIVE_COMPARATOR

Conventional treatment

Intervention Type PROCEDURE

Traditional treatment with conventional wound dressing and 5 days of immobilization after surgery.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Negative Pressure Wound Therapy

An immediate mobilization and negative pressure wound therapy (PICO) initiated after surgery.

Intervention Type DEVICE

Conventional treatment

Traditional treatment with conventional wound dressing and 5 days of immobilization after surgery.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Wound requiring skin graft surgery
* Voluntary

Exclusion Criteria

* Not voluntary
* Size of wound exceeding 15x15cm or 5x20cm
* Previous skin graft operation to the same wound
* Inability to co-operate
* Wound depth over 1.5cm
* Multiple wounds requiring skin grafting
* Active infection in wound
* Active osteomyelitis in region of wound
* Flap reconstruction of the wound
* Region of wound not suitable for negative pressure wound therapy (for example toes, foot sole)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Tampere University Hospital

OTHER

Sponsor Role collaborator

University of Eastern Finland

OTHER

Sponsor Role collaborator

Central Finland Hospital District

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Juha Paloneva, professor

Role: PRINCIPAL_INVESTIGATOR

Chief medical director

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Central Finland Hospital

Jyväskylä, , Finland

Site Status

Tampere University Hospital

Tampere, , Finland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Finland

References

Explore related publications, articles, or registry entries linked to this study.

Serra R, Rizzuto A, Rossi A, Perri P, Barbetta A, Abdalla K, Caroleo S, Longo C, Amantea B, Sammarco G, de Franciscis S. Skin grafting for the treatment of chronic leg ulcers - a systematic review in evidence-based medicine. Int Wound J. 2017 Feb;14(1):149-157. doi: 10.1111/iwj.12575. Epub 2016 Mar 4.

Reference Type BACKGROUND
PMID: 26940940 (View on PubMed)

Waltzman JT, Bell DE. Vacuum-assisted closure device as a split-thickness skin graft bolster in the burn population. J Burn Care Res. 2014 Sep-Oct;35(5):e338-42. doi: 10.1097/BCR.0000000000000009.

Reference Type BACKGROUND
PMID: 24577227 (View on PubMed)

Blume PA, Key JJ, Thakor P, Thakor S, Sumpio B. Retrospective evaluation of clinical outcomes in subjects with split-thickness skin graft: comparing V.A.C.(R) therapy and conventional therapy in foot and ankle reconstructive surgeries. Int Wound J. 2010 Dec;7(6):480-7. doi: 10.1111/j.1742-481X.2010.00728.x. Epub 2010 Sep 6.

Reference Type BACKGROUND
PMID: 20825510 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

6U/2018

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Epidermal Grafting in Wound Healing
NCT02535481 COMPLETED NA